These drugs, which open airways and reduce swelling, are a cornerstone of COPD treatment, making inhaler devices and medications the talk of the town at the Congress’ ERS panels and symposia.

Since this is a progressive disease, having a COPD treatment plan is key to breathing easier in the long term. COPD is a lung condition that restricts airflow, making breathing more difficult.

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

It is important that clinicians are able to stratify disease severity and exacerbation risk in treatment for patients with chronic obstructive pulmonary disease (COPD), says Klaus Rabe ...

COPD requires regular monitoring through tests like spirometry to assess the condition’s severity and aid in an individualized treatment plan. COPD is a progressive lung condition that makes ...

You can also talk with your doctor or pharmacist. Trelegy Ellipta has been shown to effectively treat COPD. In studies, treatment with this medication led to fewer COPD symptoms and flare-ups.

Smoking is the most common aetiologic factor. Evidence for the treatment of patients with mild-to-moderate COPD is limited. Here, the authors show that long-term treatment with high-dose N ...

Opens in a new tab or window The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on ...

This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...

Dupixent is an “add-on” drug for COPD, meaning patients take it in addition to inhaled medication Dupixent isn’t approved as a stand-alone treatment for COPD. The U.S. Food and Drug ...

The approval makes COPD the sixth indication for the blockbuster treatment and makes Dupixent the first available biologic for the condition. As per a 27 September press announcement, Dupixent ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...